Literature DB >> 17404373

Endocannabinoids and synaptic function in the CNS.

Yuki Hashimotodani1, Takako Ohno-Shosaku, Masanobu Kano.   

Abstract

Marijuana affects neural functions through the binding of its active component (Delta(9)-THC) to cannabinoid receptors in the CNS. Recent studies have elucidated that endogenous ligands for cannabinoid receptors, endocannabinoids, serve as retrograde messengers at central synapses. Endocannabinoids are produced on demand in activity-dependent manners and released from postsynaptic neurons. The released endocannabinoids travel backward across the synapse, activate presynaptic CB1 cannabinoid receptors, and modulate presynaptic functions. Retrograde endocannabinoid signaling is crucial for certain forms of short-term and long-term synaptic plasticity at excitatory or inhibitory synapses in many brain regions, and thereby contributes to various aspects of brain function including learning and memory. Molecular identities of the CB1 receptor and enzymes involved in production and degradation of endocannabinoids have been elucidated. Anatomical studies have demonstrated unique distributions of these molecules around synapses, which provide morphological bases for the roles of endocannabinoids as retrograde messengers. CB1-knockout mice exhibit various behavioral abnormalities and multiple defects in synaptic plasticity, supporting the notion that endocannabinoid signaling is involved in various aspects of neural function. In this review article, the authors describe molecular mechanisms of the endocannabinoid-mediated synaptic modulation and its possible physiological significance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404373     DOI: 10.1177/1073858406296716

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  66 in total

Review 1.  Adenosine-cannabinoid receptor interactions. Implications for striatal function.

Authors:  Sergi Ferré; Carme Lluís; Zuzana Justinova; César Quiroz; Marco Orru; Gemma Navarro; Enric I Canela; Rafael Franco; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.

Authors:  Brian D Hudson; Terence E Hébert; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS.

Authors:  Chao-Yin Chen; Ann C Bonham; Caron Dean; Francis A Hopp; Cecilia J Hillard; Jeanne L Seagard
Journal:  Auton Neurosci       Date:  2010-07-01       Impact factor: 3.145

4.  Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus.

Authors:  Yanjun Zhao; Maria Rubio; Thanos Tzounopoulos
Journal:  Hear Res       Date:  2011-03-21       Impact factor: 3.208

5.  Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release.

Authors:  Yuki Hashimotodani; Takako Ohno-Shosaku; Masahiko Watanabe; Masanobu Kano
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

6.  Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.

Authors:  Takako Ohno-Shosaku; Yuki Hashimotodani; Masato Ano; Sachi Takeda; Hiroshi Tsubokawa; Masanobu Kano
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

Review 7.  Looking for the role of cannabinoid receptor heteromers in striatal function.

Authors:  Sergi Ferré; Steven R Goldberg; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

Review 8.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.

Authors:  Ismael Galve-Roperh; Javier Palazuelos; Tania Aguado; Manuel Guzmán
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-09       Impact factor: 5.270

Review 9.  Therapeutic strategies for Alzheimer's disease.

Authors:  Donna M Barten; Charles F Albright
Journal:  Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.590

Review 10.  Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Authors:  V Kiran Vemuri; David R Janero; Alexandros Makriyannis
Journal:  Physiol Behav       Date:  2007-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.